Research Article

Hereditary Tyrosinemia Type 1 in Jordan: A Retrospective Study

Table 4

Summary of the patients’ data, .

Case numberGenderAge (years)Age at diagnosis (months)Age of symptom onset (months)Time between onset and diagnosis (months)Age of NTBC initiation (months)Interval between diagnosis and NTBC treatment (months)Growth retardationNumber of hospitalizationsCause of admissionAlive/dead

1Male144040No0Alive
2Female4.5065172No0Alive
3Male3.89313282926No0Alive
4Male7.131293156No3Abdominal painAlive
5Female5.1710122No1Chest infectionAlive
6Female3.7177070No1Chest infectionAlive
7Male2.1922020No1Electrolyte imbalanceAlive
8Female7.4712661812Yes1Electrolyte imbalanceAlive
9Male0.6720222Yes2Electrolyte imbalanceAlive
10Female6.9363363No1EncephalopathyAlive
11Male1.5911010No1FeverAlive
12Female14.42330108108No1For diagnostic workupAlive
13Male7.411239129No0For diagnostic workupAlive
14Female4.2712120120No1For diagnostic workupAlive
15Male10.4718993627No8GI bleedingsAlive
16Male6.3019514190No2Orthopedic surgery (genu varus)Alive
17Female123304814No10GI bleedingsDied
18Female53826123810Yes2Hepatic failureDied

Passed (patient number 17 died secondary to HCC; patient number 18 died secondary to hepatic failure).